India's contract drug makers seek government support in China fight

India's contract drug makers are seeking government support to remove regulatory hurdles and speed up raw material import clearances. With potential growth to $22-25 billion by 2035, the industry aims to compete globally, but currently faces delays and higher costs compared to Chinese counterparts.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/bH8MIAN
via IFTTT